Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 24 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

Legend
P
Palliative care items
MP
Medical Practitioner
MW
Midwife
NP
Nurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 8092X FAMCICLOVIRfamciclovir 125 mg tablet, 40 1 40 1
MPNP 2274Q FAMCICLOVIRfamciclovir 250 mg tablet, 20 1 20 1
MPNP 8002E FAMCICLOVIRfamciclovir 250 mg tablet, 21 1 21 0
MPNP 8217L FAMCICLOVIRfamciclovir 250 mg tablet, 56 1 56 5
MPNP 8897G FAMCICLOVIRfamciclovir 500 mg tablet, 30 1 30 0
MPNP 8896F FAMCICLOVIRfamciclovir 500 mg tablet, 56 1 56 5
MPNP 2487X FAMOTIDINEfamotidine 20 mg tablet, 60 1 60 5
MPNP 2488Y FAMOTIDINEfamotidine 40 mg tablet, 30 1 30 5
MPNP 2367N FELODIPINEfelodipine 10 mg tablet: modified release, 30 tablets 1 30 5
MPNP 2361G FELODIPINEfelodipine 2.5 mg tablet: modified release, 30 tablets 1 30 5
MPNP 2366M FELODIPINEfelodipine 5 mg tablet: modified release, 30 tablets 1 30 5
MPNP 9023X FENOFIBRATEfenofibrate 145 mg tablet, 30 1 30 5
MPNP 9022W FENOFIBRATEfenofibrate 48 mg tablet, 60 1 60 5
MPNP 5411T FENTANYLFENTANYL Lozenge 1200 micrograms (as citrate), 30 2 60 0
MPNP 5405L FENTANYLFENTANYL Lozenge 1200 micrograms (as citrate), 9 1 9 0
MPNP 5412W FENTANYLFENTANYL Lozenge 1600 micrograms (as citrate), 30 2 60 0
MPNP 5406M FENTANYLFENTANYL Lozenge 1600 micrograms (as citrate), 9 1 9 0
MPNP 5407N FENTANYLFENTANYL Lozenge 200 micrograms (as citrate), 30 2 60 0
MPNP 5401G FENTANYLFENTANYL Lozenge 200 micrograms (as citrate), 9 1 9 0
MPNP 5408P FENTANYLFENTANYL Lozenge 400 micrograms (as citrate), 30 2 60 0
MPNP 5402H FENTANYLFENTANYL Lozenge 400 micrograms (as citrate), 9 1 9 0
MPNP 5409Q FENTANYLFENTANYL Lozenge 600 micrograms (as citrate), 30 2 60 0
MPNP 5403J FENTANYLFENTANYL Lozenge 600 micrograms (as citrate), 9 1 9 0
MPNP 5410R FENTANYLFENTANYL Lozenge 800 micrograms (as citrate), 30 2 60 0
MPNP 5404K FENTANYLFENTANYL Lozenge 800 micrograms (as citrate), 9 1 9 0
MPNP 5280X FENTANYLfentanyl 100 microgram/hour patch, 5 1 5 0
MPNP 5441J FENTANYLfentanyl 100 microgram/hour patch, 5 1 5 0
MPNP 8894D FENTANYLfentanyl 100 microgram/hour patch, 5 1 5 0
MPNP 5265D FENTANYLfentanyl 12 microgram/hour patch, 5 1 5 0
MPNP 5437E FENTANYLfentanyl 12 microgram/hour patch, 5 1 5 0
MPNP 8878G FENTANYLfentanyl 12 microgram/hour patch, 5 1 5 0
MPNP 5277R FENTANYLfentanyl 25 microgram/hour patch, 5 1 5 0
MPNP 5438F FENTANYLfentanyl 25 microgram/hour patch, 5 1 5 0
MPNP 8891Y FENTANYLfentanyl 25 microgram/hour patch, 5 1 5 0
MPNP 5278T FENTANYLfentanyl 50 microgram/hour patch, 5 1 5 0
MPNP 5439G FENTANYLfentanyl 50 microgram/hour patch, 5 1 5 0
MPNP 8892B FENTANYLfentanyl 50 microgram/hour patch, 5 1 5 0
MPNP 5279W FENTANYLfentanyl 75 microgram/hour patch, 5 1 5 0
MPNP 5440H FENTANYLfentanyl 75 microgram/hour patch, 5 1 5 0
MPNP 8893C FENTANYLfentanyl 75 microgram/hour patch, 5 1 5 0
MPNP 8985X FERROUS FUMARATEferrous fumarate 200 mg (equivalent to 65.7 mg of elemental iron) tablet, 60 1 60 1
MPNP 9011G FERROUS FUMARATE + FOLIC ACIDferrous fumarate 310 mg (equivalent to 100 mg elemental iron) + folic acid 350 microgram tablet, 60 1 60 1
MPNP 8815Y FERROUS SULFATEferrous sulfate 30 mg/mL (equivalent to 6 mg/mL elemental iron) oral liquid, 250 mL 1 1 2
MPNP 1090J FLECAINIDEflecainide acetate 100 mg tablet, 60 1 60 5
MPNP 1088G FLECAINIDEflecainide acetate 50 mg tablet, 60 1 60 5
MPNP 1525G FLUCLOXACILLINflucloxacillin 1 g injection, 5 x 1 g vials 1 5 1
MPNP 9149M FLUCLOXACILLINflucloxacillin 125 mg/5 mL oral liquid: powder for, 100 mL 1 1 0
MPMWNP 1526H FLUCLOXACILLINflucloxacillin 250 mg capsule, 24 1 24 0
MPNP 9150N FLUCLOXACILLINflucloxacillin 250 mg/5 mL oral liquid: powder for, 100 mL 1 1 0
MPMWNP 1527J FLUCLOXACILLINflucloxacillin 500 mg capsule, 24 1 24 0
MPNP 1524F FLUCLOXACILLINflucloxacillin 500 mg injection, 5 x 500 mg vials 1 5 0
MPNP 1472L FLUCONAZOLEfluconazole 100 mg capsule, 28 1 28 5
MPNP 1473M FLUCONAZOLEfluconazole 100 mg/50 mL injection, 1 x 50 mL vial 7 7 0
MPNP 1475P FLUCONAZOLEfluconazole 200 mg capsule, 28 1 28 5
MPNP 1474N FLUCONAZOLEfluconazole 200 mg/100 mL injection, 1 x 100 mL vial 7 7 0
MPNP 1757L FLUCONAZOLEfluconazole 400 mg/200 mL injection, 1 x 200 mL bag 1 1 0
MPNP 1471K FLUCONAZOLEfluconazole 50 mg capsule, 28 1 28 5
MPNP 5446P FLUCONAZOLEfluconazole 50 mg/5 mL oral liquid: powder for, 35 mL 1 1 0
MPNP 1433K FLUDROCORTISONE ACETATEfludrocortisone acetate 100 microgram tablet, 100 2 200 1
MPNP 1204J FLUOROMETHOLONEfluorometholone 0.1% eye drops, 5 mL 1 1 5
MPNP 1438Q FLUOROMETHOLONE ACETATEfluorometholone acetate 0.1% eye drops, 5 mL 1 1 2
MPNP 1434L FLUOXETINEfluoxetine 20 mg capsule, 28 1 28 5
MPNP 8270G FLUOXETINEfluoxetine 20 mg tablet: dispersible, 28 1 28 5
MPNP 2257T FLUPENTHIXOL DECANOATEflupenthixol decanoate 100 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 2255Q FLUPENTHIXOL DECANOATEflupenthixol decanoate 20 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1046C FLUPHENAZINE DECANOATEfluphenazine decanoate 12.5 mg/0.5 mL injection, 5 x 0.5 mL ampoules 1 5 0
MPNP 3098C FLUPHENAZINE DECANOATEfluphenazine decanoate 25 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1001Q FLUPHENAZINE DECANOATEfluphenazine decanoate 50 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 8699W FLURBIPROFENflurbiprofen sodium 0.03% (120 microgram/0.4 mL) eye drops, 5 x 0.4 mL ampoules 1 1 0
MPNP 1417N FLUTAMIDEflutamide 250 mg tablet, 100 1 100 5
MPNP 8147T FLUTICASONEfluticasone propionate 100 microgram/actuation inhalation: powder for, 60 actuations 1 1 5
MPNP 8345F FLUTICASONEfluticasone propionate 125 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 8148W FLUTICASONEfluticasone propionate 250 microgram/actuation inhalation: powder for, 60 actuations 1 1 5
MPNP 8346G FLUTICASONEfluticasone propionate 250 microgram/actuation inhalation: pressurised, 120 actuations 1 1 1
MPNP 8516F FLUTICASONEfluticasone propionate 50 microgram/actuation inhalation: pressurised, 120 1 1 5
MPNP 8149X FLUTICASONEfluticasone propionate 500 microgram/actuation inhalation: powder for, 60 actuations 1 1 1
MPNP 10007Q FLUTICASONE + EFORMOTEROLfluticasone propionate 125 microgram/actuation + eformoterol fumarate dihydrate 5 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 10008R FLUTICASONE + EFORMOTEROLfluticasone propionate 250 microgram/actuation + eformoterol fumarate dihydrate 10 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 2827T FLUTICASONE + EFORMOTEROLfluticasone propionate 50 microgram/actuation + eformoterol fumarate dihydrate 5 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 8430Q FLUTICASONE + SALMETEROLfluticasone propionate 100 microgram/actuation + salmeterol 50 microgram/actuation inhalation: powder for, 60 actuations 1 1 5
MPNP 8518H FLUTICASONE + SALMETEROLfluticasone propionate 125 microgram/actuation + salmeterol 25 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 8519J FLUTICASONE + SALMETEROLfluticasone propionate 250 microgram/actuation + salmeterol 25 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 8431R FLUTICASONE + SALMETEROLfluticasone propionate 250 microgram/actuation + salmeterol 50 microgram/actuation inhalation: powder for, 60 actuations 1 1 5
MPNP 8517G FLUTICASONE + SALMETEROLfluticasone propionate 50 microgram/actuation + salmeterol 25 microgram/actuation inhalation: pressurised, 120 actuations 1 1 5
MPNP 8432T FLUTICASONE + SALMETEROLfluticasone propionate 500 microgram/actuation + salmeterol 50 microgram/actuation inhalation: powder for, 60 actuations 1 1 5
MPNP 8023G FLUVASTATINfluvastatin 20 mg capsule, 28 1 28 5
MPNP 8024H FLUVASTATINfluvastatin 40 mg capsule, 28 1 28 5
MPNP 2863Q FLUVASTATINfluvastatin 80 mg tablet: modified release, 28 tablets 1 28 5
MPNP 8174F FLUVOXAMINEfluvoxamine maleate 100 mg tablet, 30 1 30 5
MPNP 8512B FLUVOXAMINEfluvoxamine maleate 50 mg tablet, 30 1 30 5
MPNP 1437P FOLIC ACIDfolic acid 5 mg tablet, 100 2 200 1
MPNP 2958Q FOLIC ACIDfolic acid 500 microgram tablet, 100 2 200 0
MPNP 8775W FONDAPARINUXFONDAPARINUX SODIUM Injection 2.5 mg in 0.5 mL single dose pre-filled syringe, 2 3.5 7 0
MPNP 1182F FOSINOPRILfosinopril sodium 10 mg tablet, 30 1 30 5
MPNP 1183G FOSINOPRILfosinopril sodium 20 mg tablet, 30 1 30 5
MPNP 8400D FOSINOPRIL + HYDROCHLOROTHIAZIDEfosinopril sodium 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 8401E FOSINOPRIL + HYDROCHLOROTHIAZIDEfosinopril sodium 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPMWNP 1440T FRAMYCETIN SULFATEframycetin sulfate 0.5% (5 mg/mL) eye/ear drops, 8 mL 1 1 2
MPNP 2411X FRUSEMIDEfrusemide 10 mg/mL oral liquid, 30 mL 1 1 3
MPNP 2414C FRUSEMIDEfrusemide 20 mg tablet, 100 1 100 1
MPNP 1810G FRUSEMIDEfrusemide 20 mg tablet, 50 2 100 1
MPNP 2413B FRUSEMIDEfrusemide 20 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 3466K FRUSEMIDEfrusemide 20 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 2412Y FRUSEMIDEfrusemide 40 mg tablet, 100 1 100 1
MPNP 2415D FRUSEMIDEfrusemide 500 mg tablet, 50 1 50 3